Compounds and compositions as sppl2a inhibitors

NZ837006APending Publication Date: 2026-09-25NOVARTIS AG

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: NZ837006
Authority / Receiving Office: NZ · NZ
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2020-09-17
Filing Date: 2021-09-15
Publication Date: 2026-09-25

Application Information

Patent Timeline

17 Sep 2020

Priority

15 Sep 2021

Application

NZ837006

25 Sep 2026

Publication

NZ837006A

IPC: C07D487/04; A61P35/00; A61K31/551

Inventors: BRANDL, TRIXI; EHRHARDT, CLAUS

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to tricyclic compounds comprising a diazepinone moiety which are effective in inhibiting Sppl2a (signal peptide peptidase like protease 2a), to pharmaceutical compositions containing such inhibitors, and to methods of using such inhibitors and compositions.

Need to check novelty before this filing date? Find Prior Art